Tag: lipoprotein(a)

19-HVI-1792159; Steven Nissen, M.D., M.A.C.C.; Mike Viars
January 4, 2024/Preventive Cardiology

Lipoprotein(a): Progress on One of the Last Untreatable Frontiers of Cardiovascular Risk

It's time to increase testing for this major cardiovascular risk factor in advance of new therapies

November 13, 2023/Preventive Cardiology

Novel siRNA Reduces Lipoprotein(a) by More Than 90% for 48 Weeks

Undetectable levels achieved for nearly nine months in phase 1 trial

April 4, 2022/Preventive Cardiology

Novel siRNA Therapy Lowers Elevated Plasma Lipoprotein(a) in Phase 1 APOLLO Trial

Targeted mRNA blocking could be first effective approach specific to this cardiovascular risk factor

lipoprotein(a) particle
January 13, 2020/News & Insights

Elevated Lipoprotein(a): Is a Long-Sought Treatment Finally on the Way?

New phase 2 data boost hopes for phase 3 Lp(a) HORIZON trial


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

November 15, 2018/News & Insights

AHA 2018 Essentials: Dr. Steve Nissen on What Mattered Most (Video)

Cholesterol guideline, vitamin D, REDUCE-IT and lipoprotein(a)

BackPage 1 of 1Next